CVS Coram: Revolutionizing Pharmacy With Unmatched Convenience - mail
Webcvs caremark corporation (nyse:cvs) recently completed the $2. 1 billion acquisition of drug infusion services provider coram llc.
Webin an effort to develop its specialty pharmacy business, cvs caremark (nyse:cvs) unveiled a $2. 1 billion deal on wednesday to acquire the specialty infusion.
Completed its $2. 1 billion acquisition of the drug infusion business coram llc, and it expects the deal to start helping earnings.
Recommended for you
Webdrugstore chain cvs caremark corp.
🔗 Related Articles You Might Like:
The Job Oracle Predicting Your Destiny On Craigslist Worcester Ma Exclusive: Whistleblower Exposes Ky3 News's Fabricated Stories Things You Didn't Know About Zillow Real: Unlocking The Secrets📸 Image Gallery
You may also like